Selz Capital Decreased Its Callon Petroleum (CPE) Position by $1.30 Million; United Asset Strategies Has Trimmed Its Gilead Sciences (GILD) Stake as Market Value Declined

December 8, 2017 - By Vivian Park

United Asset Strategies Inc decreased its stake in Gilead Sciences Inc (GILD) by 22.74% based on its latest 2017Q2 regulatory filing with the SEC. United Asset Strategies Inc sold 19,403 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 65,941 shares of the health care company at the end of 2017Q2, valued at $4.67 million, down from 85,344 at the end of the previous reported quarter. United Asset Strategies Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $94.99 billion market cap company. The stock decreased 0.78% or $0.57 during the last trading session, reaching $72.72. About 6.17M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since December 8, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Bernard Selz decreased its stake in Callon Petroleum Corp (CPE) by 65% based on its latest 2017Q2 regulatory filing with the SEC. Selz Capital Llc sold 130,000 shares as the company’s stock declined 11.69% while stock markets rallied. The hedge fund run by Bernard Selz held 70,000 shares of the oil & gas production company at the end of 2017Q2, valued at $743,000, down from 200,000 at the end of the previous reported quarter. Selz Capital Llc who had been investing in Callon Petroleum Corp for a number of months, seems to be less bullish one the $2.16 billion market cap company. The stock decreased 0.56% or $0.06 during the last trading session, reaching $10.7. About 3.65M shares traded. Callon Petroleum Company (NYSE:CPE) has risen 12.29% since December 8, 2016 and is uptrending. It has underperformed by 4.41% the S&P500.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It improved, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. 68,920 were accumulated by Glg Limited Liability Corp. The Maine-based Bangor State Bank has invested 0.28% in Gilead Sciences, Inc. (NASDAQ:GILD). Regent Inv Mgmt Ltd Co holds 0.51% or 20,617 shares. Cim Investment Mangement Inc holds 0.32% or 12,681 shares. First Midwest Bank Tru Division owns 28,872 shares. Usca Ria Ltd Liability Corporation holds 0.67% or 74,226 shares. Fin Pro holds 0.01% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 389 shares. Highbridge Cap Mgmt Llc holds 0.24% or 226,232 shares. Jefferies Group Inc Ltd Co has invested 0% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Lyons Wealth Mgmt Ltd Liability Corporation has 13,966 shares for 1.38% of their portfolio. Retirement Of Alabama invested 0.38% in Gilead Sciences, Inc. (NASDAQ:GILD). 26,226 were reported by Doheny Asset Management Ca. Marshall Wace Limited Liability Partnership has invested 0.51% in Gilead Sciences, Inc. (NASDAQ:GILD). Chickasaw Capital Ltd holds 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 22,100 shares. One Cap Management Ltd owns 0.6% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 28,653 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. As per Wednesday, July 29, the company rating was maintained by RBC Capital Markets. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, November 2. The company was maintained on Wednesday, February 3 by RBC Capital Markets. The company was maintained on Wednesday, October 4 by RBC Capital Markets. The firm has “Hold” rating given on Monday, November 13 by Argus Research. The company was maintained on Wednesday, November 8 by Mizuho. Bank of America upgraded the stock to “Neutral” rating in Monday, January 18 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Wednesday, August 31 by Jefferies. Credit Suisse maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, September 14. Credit Suisse has “Outperform” rating and $95 target. The firm earned “Outperform” rating on Wednesday, November 2 by BMO Capital Markets.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead – Another Sobering Moment, But There Is More” on November 28, 2017, also Seekingalpha.com with their article: “Gilead Sciences: Are You Willing To Wait 3 Years?” published on November 27, 2017, Seekingalpha.com published: “Gilead: Attractive After Big Retreat?” on November 24, 2017. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: Buying New Growth” published on November 22, 2017 as well as Businesswire.com‘s news article titled: “Gilead Announces 10-Year, $100 Million Commitment to Address the HIV/AIDS …” with publication date: December 04, 2017.

United Asset Strategies Inc, which manages about $731.00 million and $337.15M US Long portfolio, upped its stake in Visa Inc (NYSE:V) by 3,873 shares to 8,071 shares, valued at $757,000 in 2017Q2, according to the filing. It also increased its holding in Proshares Tr by 15,655 shares in the quarter, for a total of 34,460 shares, and has risen its stake in Firstenergy Corp (NYSE:FE).

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 EPS, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18 billion for 10.89 P/E if the $1.67 EPS becomes a reality. After $2.23 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Among 30 analysts covering Callon Petroleum (NYSE:CPE), 28 have Buy rating, 0 Sell and 2 Hold. Therefore 93% are positive. Callon Petroleum has $26 highest and $8 lowest target. $15.33’s average target is 43.27% above currents $10.7 stock price. Callon Petroleum had 77 analyst reports since July 21, 2015 according to SRatingsIntel. Imperial Capital maintained the stock with “Outperform” rating in Tuesday, February 9 report. The rating was maintained by Northland Capital with “Buy” on Monday, August 21. The rating was maintained by JP Morgan with “Overweight” on Tuesday, March 15. The company was downgraded on Tuesday, September 8 by Cowen & Co. The stock of Callon Petroleum Company (NYSE:CPE) has “Buy” rating given on Thursday, July 13 by Citigroup. The company was maintained on Friday, September 9 by FBR Capital. The rating was initiated by Bank of America with “Buy” on Tuesday, October 17. The firm has “Buy” rating given on Thursday, July 6 by RBC Capital Markets. iBERIA Capital Partners maintained Callon Petroleum Company (NYSE:CPE) on Thursday, April 28 with “Outperform” rating. The company was downgraded on Wednesday, June 21 by Seaport Global.

Analysts await Callon Petroleum Company (NYSE:CPE) to report earnings on February, 26. They expect $0.11 EPS, up 37.50% or $0.03 from last year’s $0.08 per share. CPE’s profit will be $22.21M for 24.32 P/E if the $0.11 EPS becomes a reality. After $0.09 actual EPS reported by Callon Petroleum Company for the previous quarter, Wall Street now forecasts 22.22% EPS growth.

More important recent Callon Petroleum Company (NYSE:CPE) news were published by: Livetradingnews.com which released: “Callon Petroleum Company (NYSE:CPE) Declines 5.45%” on December 07, 2017, also Prnewswire.com published article titled: “Callon Petroleum Appoints James Ulm as Chief Financial Officer”, Prnewswire.com published: “Callon Petroleum Company Announces Upcoming Investor Events” on November 17, 2017. More interesting news about Callon Petroleum Company (NYSE:CPE) was released by: Seekingalpha.com and their article: “Callon Ride Along (Part 1)” with publication date: November 29, 2017.

Investors sentiment decreased to 1.73 in 2017 Q2. Its down 0.03, from 1.76 in 2017Q1. It fall, as 38 investors sold CPE shares while 55 reduced holdings. 33 funds opened positions while 128 raised stakes. 229.70 million shares or 2.94% more from 223.13 million shares in 2017Q1 were reported. Fifth Third Fincl Bank owns 26,911 shares for 0% of their portfolio. Baker Avenue Asset Mngmt Ltd Partnership owns 0.14% invested in Callon Petroleum Company (NYSE:CPE) for 96,710 shares. Raymond James holds 204,960 shares. Brant Point Inv Management Limited Liability Corp invested in 250,700 shares. Connor Clark And Lunn Invest Management Limited reported 2.75 million shares or 0.19% of all its holdings. Wellington Group Llp reported 19.06M shares. E&G Ltd Partnership reported 0.27% in Callon Petroleum Company (NYSE:CPE). Parallax Volatility Advisers LP invested 0% of its portfolio in Callon Petroleum Company (NYSE:CPE). Susquehanna International Gp Limited Liability Partnership stated it has 0% of its portfolio in Callon Petroleum Company (NYSE:CPE). Td Asset Management holds 398,700 shares or 0.01% of its portfolio. Miller Howard Inc owns 642,663 shares for 0.14% of their portfolio. Agf Investments has invested 0.01% in Callon Petroleum Company (NYSE:CPE). Rhumbline Advisers invested 0.01% of its portfolio in Callon Petroleum Company (NYSE:CPE). Pnc Financial Services Gp stated it has 18,990 shares or 0% of all its holdings. Glenmede Trust Com Na reported 1.94M shares or 0.12% of all its holdings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.